One potential therapeutic approach is targeting TERT expression, which is essential for tumor growth.42 A previous study confirmed that silencing TERT, or its tumor-specific promoter GABPB1, is an effective therapeutic approach.21 Another potential therapeutic approach is to target EGFR since EGFR amplifications occur commonly in GBM. The gene discussed is GABPB1; the disease is neoplasm.